Diagnosing the Problem
In today’s interconnected world, we are currently faced with many global challenges and opportunities surrounding infectious diseases. At Alveo, we’re tackling these head-on by creating technology platforms that provide rapid, reliable, and economical cloud-based diagnostics for use by anyone, at any time and everywhere.
Discovering the Solution
Alveo is poised to create a new ecosystem for the detection of infectious diseases by combining unprecedented nucleic acid detection with molecular biochemistry in a highly efficient design package.
Alveo’s cloud-strengthened product platform enables the creation of vast datasets to help track global infectious disease outbreaks and connect individuals with treatments.
Alveo overcomes the limitations of current diagnostic methods, by condensing all of the necessary steps for infectious detection into a single step process.
Sample preparation, nucleic acid amplification and real-time detection are all performed in a single isothermal microfluidic channel.
The highlight of this all-inclusive design approach is multiplexing, and the Alveo platform will multiplex 100 or more simultaneous tests from a single sample.